Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study - Concepedia

Concepedia

Publication | Closed Access

Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

18

Citations

30

References

2014

Year

Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, Donald A. Molony, Cynthia Bell, Domenico Russo, Biagio Di Iorio

Journal of Nephrology

Abstract

Sevelamer is a cost-effective alternative to calcium carbonate for the first-line treatment of hyperphosphatemia in new to HD patients in Italy.

References

	Year	Citations

Page 1